Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Doseology Sciences, Inc. ( (TSE:MOOD) ).
Doseology Sciences Inc. has completed a debt settlement by issuing 100,000 common shares at $0.165 per share to settle $16,500 of a $39,000 total debt for past consulting services. The remaining $22,500 will be paid in cash. This strategic move helps Doseology manage its financial obligations while maintaining its focus on enhancing its market position and delivering value to its stakeholders.
More about Doseology Sciences, Inc.
Doseology Sciences Inc. specializes in premium functional mushroom supplements that are science-backed and formulated by health experts. The company focuses on optimizing wellness through high-purity liquid format mushroom supplements for faster absorption.
YTD Price Performance: -30.0%
Average Trading Volume: 6,180
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$596.1K
For an in-depth examination of MOOD stock, go to TipRanks’ Stock Analysis page.